These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22373833)

  • 1. Once daily nifedipine: the formulation dictates the pharmacokinetic characteristics and the therapeutic responses.
    Toal CB; Meredith PA; Elliott HL
    Int J Clin Pharmacol Ther; 2012 Mar; 50(3):202-17. PubMed ID: 22373833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.
    Grundy JS; Foster RT
    Clin Pharmacokinet; 1996 Jan; 30(1):28-51. PubMed ID: 8846626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: a literature review comparing amlodipine and nifedipine GITS.
    Toal CB; Meredith PA; Elliott HL
    Blood Press; 2012 Jul; 21 Suppl 1(Suppl 1):3-10. PubMed ID: 22762301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension. Nifedipine Study Group.
    Glasser SP; Jain A; Allenby KS; Shannon T; Pride K; Pettis PP; Schwartz LA; MacCarthy EP
    Clin Ther; 1995; 17(1):12-29. PubMed ID: 7758054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.
    Murdoch D; Brogden RN
    Drugs; 1991 May; 41(5):737-79. PubMed ID: 1712708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine gastrointestinal therapeutic system (GITS). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and angina pectoris.
    Brogden RN; McTavish D
    Drugs; 1995 Sep; 50(3):495-512. PubMed ID: 8521771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of long-acting nifedipine tablets influences the heart rate and sympathetic nervous system response in hypertensive patients.
    Brown MJ; Toal CB
    Br J Clin Pharmacol; 2008 May; 65(5):646-52. PubMed ID: 18093252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension.
    Kirby BJ; Kitchin NR
    Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative drug delivery systems in cardiovascular medicine: nifedipine-GITS and clonidine-TTS.
    Frishman WH; Sherman D; Feinfeld DA
    Cardiol Clin; 1987 Nov; 5(4):703-16. PubMed ID: 3331321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris.
    Croom KF; Wellington K
    Drugs; 2006; 66(4):497-528. PubMed ID: 16597165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nifedipine GITS replacing nifedipine SR: ambulatory blood pressure assessment of efficacy.
    Rahima-Maoz C; Grossman E; Nussinovitch N; Katz A; Rosenthal T
    Cardiology; 1997; 88 Suppl 3():43-6. PubMed ID: 9397293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily therapy for angina pectoris with nifedipine gastrointestinal therapeutic system. Dosing and clinical efficacy.
    Vetrovec GW
    Am J Med; 1989 Jan; 86(1A):28-32. PubMed ID: 2644830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of once-daily nifedipine administered without food: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate hypertension. Nifedipine Study Group.
    Glasser SP; Ripa SR; Allenby KS; Schwartz LA; Commins BM; Jungerwirth S
    Clin Ther; 1995; 17(2):296-312. PubMed ID: 7614530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine Gastrointestinal Therapeutic System (GITS) in the treatment of coronary heart disease and hypertension.
    Kragten JA; Dunselman PH
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):643-53. PubMed ID: 17605643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 24-hour ambulatory blood pressure data in hypertensive patients switched from nifedipine-GITS to nifedipine-CC.
    Wurdeman RL; Mooss AN; Mohiuddin SM; Lucas BD; Ryschon KL; Hilleman DE
    Pharmacotherapy; 1999 Jan; 19(1):94-100. PubMed ID: 9917082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of nifedipine GITS in the treatment of hypertension: an overview.
    Simon A; Levenson J
    Expert Opin Pharmacother; 2003 Jan; 4(1):95-106. PubMed ID: 12517246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Palmer CR; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    Lancet; 2000 Jul; 356(9227):366-72. PubMed ID: 10972368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low-dose nifedipine GITS on sympathetic activity in young and older patients with hypertension.
    Ruzicka M; Coletta E; Floras J; Leenen FH
    J Hypertens; 2004 May; 22(5):1039-44. PubMed ID: 15097246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.